Indications
Therapeutic Asset Ratings
3,186 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ex-Vivo Expanded Γδ T Cell Infusion
Lymphoma
Chinese PLA General Hospital
P1/2
CC
(41)
Ex-Vivo Expanded Γδ T Cell Infusion
Myelodysplastic Syndrome
Chinese PLA General Hospital
P1/2
CC
(41)
fhb7h3.car-ts
Hepatocellular Carcinoma
The Affiliated Hospital of Xuzhou Medical University
P1/2
CC
(41)
Hbi 0201-Eso Tcrt
Non-Small Cell Lung Carcinoma
Hadassah Medical Organization
P1/2
CC
(41)
Hbi 0201-Eso Tcrt
Triple-Negative Breast Carcinoma
Hadassah Medical Organization
P1/2
CC
(41)
her2bbζ/cd19t+ t cells
Gastric Cancer
Shanghai Public Health Clinical Center
P1/2
CC
(41)
her2bbζ/cd19t+ t cells
Hepatocellular Carcinoma
Shanghai Public Health Clinical Center
P1/2
CC
(41)
her2bbζ/cd19t+ t cells
Renal Cell Carcinoma
Shanghai Public Health Clinical Center
P1/2
CC
(41)
her2bbζ/cd19t+ t cells
Small Cell Lung Carcinoma
Shanghai Public Health Clinical Center
P1/2
CC
(41)
Human Leukocyte
Neoplasm
Dipnarine Maharaj
P1/2
CC
(41)
Human Placenta-Derived 3D Mesenchymal Stem Cells
Ischemic Stroke
Chinese PLA General Hospital
P1/2
CC
(41)
Icasp9M28Z T Cell Infusions
Lung Cancer
Memorial Sloan Kettering Cancer Center
P1/2
CC
(41)
IM19 CAR-T cells
Lymphoma
Beijing Immunochina Medical Science & Technology Co., Ltd.
P1/2
CC
(41)
Ksq-001Ex
Melanoma
M.D. Anderson Cancer Center
P1/2
CC
(41)
Mutant Kras G12V-Specific Tcr Transduced Autologous T Cells
Pancreatic Ductal Adenocarcinoma
Changhai Hospital
P1/2
CC
(41)
Nadravaleucel
Head And Neck Squamous Cell Carcinoma
NKGen Biotech, Inc.
P1/2
CC
(41)
Neoantigen Specific Tcr-T Cell Drug Product
Endometrial Carcinoma
Alaunos Therapeutics
P1/2
CC
(41)
Neural Stem Cells
Ischemic Stroke
Gary Steinberg, MD, PhD
P1/2
CC
(41)
Obx-115
Lung Cancer
Obsidian Therapeutics, Inc.
P1/2
CC
(41)
Obx-115
Non-Small Cell Lung Carcinoma
Obsidian Therapeutics, Inc.
P1/2
CC
(41)
Ori-C101
Hepatocellular Carcinoma
OriCell Therapeutics Co., Ltd.
P1/2
CC
(41)
Rivogenlecleucel
Myelodysplastic Syndrome
Fred Hutchinson Cancer Center
P2/3
CC
(41)
Satricabtagene Autoleucel
Gastric Cancer
CARsgen Therapeutics Co., Ltd.
P1/2
CC
(41)
Scri-Car22V2
Leukemia
Seattle Children's Hospital
P1/2
CC
(41)
Scri-Car22V2
Lymphoma
Seattle Children's Hospital
P1/2
CC
(41)
Showing 2126 to 2150 of 3,186 assets
Previous
Page 86 of 128
Next
